Graduate Institute Geneva - Global Health Centre "The Covid-19 pandemic has driven extraordinary scientific efforts to develop effective and safe vaccines. With several vaccines being distributed and dozens of candidates in late-stage development, countries are concluding purchasing and manufacturing agreements with pharmaceutical companies to immunise their populations. In order to shed light on which countries may get access to which vaccine, at what prices and when, the Global Health Centre recently published an open dataset on Covid-19 vaccine purchasing and manufacturing arrangements. This new resource tracks and analyses publicly available data on agreements to manufacture, purchase, supply and/or donate Covid-19 vaccines. (...) Many high-income countries have now secured enough doses to cover their populations twice over, but most other countries have only secured doses to cover less than 50% of their populations."
